Cargando…
Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage
BACKGROUND: There are limited neuroprotective treatment options for patients with aneurysmal subarachnoid hemorrhage (SAH). Cerebrolysin, a brain-specific proposed pleiotropic neuroprotective agent, has been suggested to improve global functional outcomes in ischemic stroke. We investigated the effi...
Autores principales: | Woo, Peter Y. M., Ho, Joanna W. K., Ko, Natalie M. W., Li, Ronald P. T., Jian, Leo, Chu, Alberto C. H., Kwan, Marco C. L., Chan, Yung, Wong, Alain K. S., Wong, Hoi-Tung, Chan, Kwong-Yau, Kwok, John C. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607674/ https://www.ncbi.nlm.nih.gov/pubmed/33143640 http://dx.doi.org/10.1186/s12883-020-01908-9 |
Ejemplares similares
-
Cerebrolysin for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review
por: Park, Yung Ki, et al.
Publicado: (2018) -
Correction to: Cerebrolysin for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review
por: Park, Yung Ki, et al.
Publicado: (2019) -
Review and recommendations on management of refractory raised intracranial pressure in aneurysmal subarachnoid hemorrhage
por: Mak, Calvin Hoi Kwan, et al.
Publicado: (2013) -
Cerebrolysin in Patients with Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis
por: Kojder, Klaudyna, et al.
Publicado: (2023) -
Circulating MicroRNAs in Delayed Cerebral Infarction After Aneurysmal Subarachnoid Hemorrhage
por: Lu, Gang, et al.
Publicado: (2017)